- SmartAsset provides vetted financial advice tools for retirement planning.
- Financial planning tools are being used to match advisors for retirement planning, with state tax policy impacting dividend income for companies like P&G, J&J, and NextEra in Pennsylvania.
SmartAsset offers tools for investors to evaluate dividend stocks, including Coca-Cola and Procter & Gamble.
2 reports, 1 independent
Updated Jul 17
Gone quiet
- Reports
- 2
- Developments
- 4
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
SmartAsset offers tools for investors to evaluate dividend stocks, including Coca-Cola and Procter & Gamble.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Coca-Cola and its executive Carol Tomé are being analyzed for their dividend stock performance.Sub-event
- Investors are concerned about how dividend taxation rules affect Coca-Cola dividend investments.Sub-event
- SmartAsset offers free tools to match users with vetted financial advisors while dividend-paying companies like Coca-Cola announce dividend increases.Sub-event
SmartAsset provides tools for evaluating dividend stocks like Coca-Cola and P&G.1 source
Keep exploring
The entities involved
-
Coca-Cola
carbonated brown-colored soft drink
-
SmartAsset
American financial technology company
-
Procter & Gamble
American multinational consumer goods corporation
Related events
- Coca-Cola and Johnson & Johnson announced dividend raises, while SmartAsset continues to assist users with retirement planning.
- Procter & Gamble and Coca-Cola were included in the same dividend index on November 2, 2026.
- Procter & Gamble, Johnson & Johnson, Coca-Cola, and Verizon are discussed as income-generating companies referenced in dividend investment strategies.
- The Schwab U.S. Dividend Equity ETF now includes Procter & Gamble, Abbott Laboratories, and Merck among its top 10 holdings.